<DOC>
	<DOCNO>NCT02097719</DOCNO>
	<brief_summary>This efficacy safety study evaluate LUMIGAN® .01 ( bimatoprost 0.01 % ) alone compare TRAVATAN Z® ( travoprost 0.004 % ) TIMOLOL GFS , 0.5 % ( timolol 0.5 % ophthalmic gel form solution ) patient require IOP lower therapy .</brief_summary>
	<brief_title>Efficacy Safety Study Bimatoprost 0.01 % Alone Compared With Travoprost 0.004 % Timolol 0.5 % Subjects With Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>Ocular hypertension glaucoma require treatment medication Have best correct visual acuity ( BCVA ) 20/100 good eye History LASIK , LASEK , RK , and/or PRK study eye ( ) History intraocular surgery glaucoma laser surgery study eye ( ) within 3 month Use topical , periorbital , intravitreal systemic steroid within 3 month expect use course study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>